Salvia BioElectronics nets $60M to develop minimally invasive migraine implant
Salvia BioElectronics’ neuromodulation device, with paper-thin implants placed under the skin at the front and back of the head, is being tested in a blinded study.
Salvia BioElectronics’ neuromodulation device, with paper-thin implants placed under the skin at the front and back of the head, is being tested in a blinded study.
